Have a personal or library account? Click to login
Ex vivo permeability study and in vitro solubility characterization of oral Canagliflozin self-nanomicellizing solid dispersion using Soluplus® as a nanocarrier Cover

Ex vivo permeability study and in vitro solubility characterization of oral Canagliflozin self-nanomicellizing solid dispersion using Soluplus® as a nanocarrier

Open Access
|Jul 2024

References

  1. Liu X, Zhou L, Zhang F. Reactive melt extrusion to improve the dissolution performance and physical stability of naproxen amorphous solid dispersions. Mol Pharm. 2017;14(3):658–673.
  2. Djuric D, Soluplus. Solubility enhancement with BASF pharma polymers. Reintjes T, editor. BASF SE. 2011; 5:67–72.
  3. Parikh A, Kathawala K, Tan CC, Garg S, Zhou X-F. Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement. Drug Des Devel Ther [Internet]. 2018;12:2051–2069.
  4. Hou Y, Wang H, Zhang F, Sun F, Xin M, Li M, et al. Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatforms for oral delivery of curcumin. Int J Nanomedicine [Internet]. 2019;14:557–571.
  5. Younis MA, Tawfeek HM, Abdellatif AAH, Abdel-Aleem JA, Harashima H. Clinical translation of nanomedicines: Challenges, opportunities, and keys. Adv Drug Deliv Rev. 2022;181(114083):114083.
  6. BNF. Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society. 66-68 East Smithfield, London E1W1AW,UK; 83:2022;769-771.
  7. Singh D, Singh AP, Singh D, Kesavan AK, Arora S, Tiwary AK, et al. Enhanced oral bioavailability and anti-diabetic activity of canagliflozin through a spray dried lipid based oral delivery: a novel paradigm. Daru.2020;28(1):191–208.
  8. Patel NC, Patel HA. A recent solidification approach for nanosuspension: formulation, optimization, and evaluation of canagliflozin immediate release pellets. Folia Med (Plovdiv) [Internet]. 2022;64(3):488–500.
  9. Jassem NA, Abd Alhammid SN. Enhancement of the dissolution and solubility of canagliflozin using nanodispersion systems. Al-Rafidain J Med Sci [Internet]. 2024;6(1):222–31.
  10. Higuchi T, Connors KA. Phase-Solubility Techniques. In: Reilly CN, editor. Advances in Analytical Chemistry and Instrumentation. New York: Wiley-Interscience; 1965. p. 117–212.
  11. Obayes KK, Thomas LM. Development and characterization of hyaluronic acid-incorporated Thermosensitive nasal in situ gel of meclizine hydrochloride. Al-Rafidain J Med Sci [Internet]. 2024;6(1):97–104.
  12. Wang H, He Y, Hou Y, Geng Y, Wu X. Novel self-nanomicellizing formulation based on Rebaudioside A: A potential nanoplatforms for oral delivery of naringenin. Mater Sci Eng C Mater Biol Appl. 2020;112(110926):110926.
  13. Salim FF, A. Rajab N. Formulation and characterization of piroxicam as self-nano emulsifying drug delivery system. Iraqi J Pharm Sci. 2020;29(1):174–183.
  14. Feng S, Zhang Z, Almotairy A, Repka MA. Development and Evaluation of polymeric mixed micelles prepared using hot-melt extrusion for extended delivery of poorly water-soluble drugs. J Pharm Sci . 2023;112(11):2869–2878.
  15. Lu P, Liang Z, Zhang Z, Yang J, Song F, Zhou T, et al. Novel nanomicelle butenafine formulation for ocular drug delivery against fungal keratitis: In Vitro and In Vivo study. Eur J Pharm Sci 2024;192(106629):106629. http://dx.doi.org/10.1016/j.ejps.2023.106629
  16. Abd allatif K, Hasian JA. Preparation and in vitro evaluation for different types of Ondansetron hydrochloride transdermal patches. Iraqi J Pharm Sci. 2023;32(1):147–155.
  17. Hamed HE, A. Hussein A. Preparation, in vitro and ex-vivo Evaluation of Mirtazapine Nanosuspension and Nanoparticles Incorporated in Orodispersible Tablets. Iraqi J Pharm Sci. 2020;29(1):62–75.
  18. Noor AD, BH. Al-Khedairy E. Formulation and Evaluation of Silymarin Microcrystals by In-Situ Micronization Technique. Iraqi J Pharm Sci. 2019;28(1):1–16.
  19. Singh D, Bedi N, Tiwary AK, Kurmi BD, Bhattacharya S. Natural bio functional lipids containing solid self-micro emulsifying drug delivery system of Canagliflozin for synergistic prevention of type 2 diabetes mellitus. J Drug Deliv Sci Technol 2022;69(103138):103138.
  20. Singh D, Tiwary AK, Bedi N. Role of porous carriers in the biopharmaceutical performance of solid SMEDDS of canagliflozin. Recent Pat Drug Deliv Formul. 2019;12(3):179–98.
  21. Tamer MA, Kassab HJ. The Development of a brain-targeted mucoadhesive amisulpride-loaded nanostructured lipid carrier. Farmacia. 2023;71(5):1032–1044.
  22. Nekkanti V, Wang Z, Betageri GV. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes versus self-nanoemulsifying drug delivery system. AAPS PharmSciTech. 2016;17(4):851–862.
  23. Ali SK, Al-Akkam EJM. Oral nanobilosomes of ropinirole: preparation, compatibility and Ex-vivo intestinal absorption study. J Adv Pharm Educ Res. 2023;13(4):8–15.
  24. Jaber SH, Rajab NA. Preparation, in-vitro, ex-vivo, and pharmacokinetic study of lasmiditan as intranasal nanoemulsion-based in situ gel. Pharm Nanotechnol 2024;12.
  25. Zhang X, Li J, Rong R, Wang D, Wang D, Yu Y, et al. Enhancing the oral bioavailability of poorly water-soluble amisupiride with solid nanodispersion. J Drug Deliv Sci Technol. 2023;86(104635):104635.
  26. Pignatello R, Corsaro R, Bonaccorso A, Zingale E, Carbone C, Musumeci T. Soluplus® polymeric nanomicelles improve the solubility of BCS-class II drugs. Drug Deliv Transl Res. 2022;12(8):1991–2006.
  27. Alvarez-Rivera F, Fernández-Villanueva D, Concheiro A, Alvarez-Lorenzo C. Α-lipoic acid in soluplus® polymeric nanomicelles for ocular treating diabetes-associated corneal diseases. J Pharm Sci . 2016;105(9):2855–2863.
  28. Bergonzi MC, Vasarri M, Marroncini G, Barletta E, Degl’Innocenti D. Thymoquinone-loaded soluplus®-Solutol® HS15 mixed micelles: Preparation, in vitro characterization, and effect on the SH-SY5Y cell migration. Molecules. 2020;25(20):4707.
  29. Ha E-S, Baek I-H, Cho W, Hwang S-J, Kim M-S. Preparation and Evaluation of solid dispersion of atorvastatin calcium with Soluplus® by spray drying technique. Chem Pharm Bull (Tokyo). 2014;62(6):545–551.
  30. Sun M, Zhai X, Xue K, Hu L, Yang X, Li G, et al. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-micro emulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. Eur J Pharm Sci. 2011;43(3):132–140.
  31. Nekkanti V, Wang Z, Betageri GV. Pharmacokinetic Evaluation of Improved Oral Bioavailability of Valsartan: Proliposomes versus self-nanoemulsifying drug delivery system. AAPS Pharm Sci Tech. 2016;17(4):851–862.
DOI: https://doi.org/10.2478/amma-2024-0011 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 42 - 49
Submitted on: Feb 19, 2024
|
Accepted on: May 10, 2024
|
Published on: Jul 3, 2024
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2024 Nizar Awish Jassem, Shaimaa Nazar Abd Alhammid, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.